Church & Dwight (NYSE:CHD – Get Free Report) issued an update on its fourth quarter earnings guidance on Friday morning. The company provided EPS guidance of $0.76 for the period, compared to the consensus EPS estimate of $0.86. The company issued revenue guidance of +1.5-2.5% yr/yr to ~$1.55-1.57 billion, compared to the consensus revenue estimate of $1.57 billion. Church & Dwight also updated its FY 2024 guidance to 3.420-3.420 EPS.
Church & Dwight Price Performance
NYSE CHD traded down $1.83 on Monday, hitting $102.92. 672,761 shares of the company were exchanged, compared to its average volume of 1,369,236. The firm has a 50 day moving average of $102.89 and a two-hundred day moving average of $104.03. The company has a market cap of $25.20 billion, a P/E ratio of 31.99, a P/E/G ratio of 3.69 and a beta of 0.55. The company has a current ratio of 1.53, a quick ratio of 0.98 and a debt-to-equity ratio of 0.51. Church & Dwight has a 1-year low of $86.23 and a 1-year high of $110.31.
Church & Dwight (NYSE:CHD – Get Free Report) last announced its quarterly earnings results on Friday, November 1st. The company reported $0.79 EPS for the quarter, beating analysts’ consensus estimates of $0.68 by $0.11. Church & Dwight had a return on equity of 19.86% and a net margin of 13.38%. The company had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.50 billion. During the same period in the prior year, the business posted $0.74 EPS. Church & Dwight’s revenue was up 3.8% on a year-over-year basis. On average, equities analysts predict that Church & Dwight will post 3.43 EPS for the current year.
Church & Dwight Announces Dividend
Wall Street Analyst Weigh In
Several analysts recently weighed in on the company. Evercore ISI reduced their price objective on Church & Dwight from $110.00 to $101.00 and set an “in-line” rating on the stock in a research note on Monday, August 5th. Stifel Nicolaus cut their price objective on Church & Dwight from $107.00 to $105.00 and set a “hold” rating on the stock in a research note on Monday, August 5th. Wells Fargo & Company lifted their price objective on Church & Dwight from $113.00 to $115.00 and gave the stock an “overweight” rating in a research note on Monday. Piper Sandler assumed coverage on Church & Dwight in a report on Tuesday, September 24th. They issued an “overweight” rating and a $120.00 target price for the company. Finally, JPMorgan Chase & Co. boosted their price objective on Church & Dwight from $98.00 to $99.00 and gave the company an “underweight” rating in a report on Monday. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have given a buy rating to the stock. According to MarketBeat, Church & Dwight presently has a consensus rating of “Hold” and an average price target of $107.90.
Church & Dwight Company Profile
Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.
Further Reading
- Five stocks we like better than Church & Dwight
- What Are Dividend Challengers?
- Intel: Is Now the Time to Be Brave?Â
- What is a SEC Filing?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is a buyback in stocks? A comprehensive guide for investors
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Church & Dwight Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Church & Dwight and related companies with MarketBeat.com's FREE daily email newsletter.